Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)

NCT00412750 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

159

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment stopped for safety issues

Conditions

Hepatitis B

Interventions

DRUG: Telbivudine (LdT)
DRUG: peginterferon alpha-2a

Sponsor

Novartis